DLA Piper advises Kartos Therapeutics in acquisition by Ipsen for up to US$1.75 billion
29 June 2026 .2 minute read
Inside Competition: June 2026
17 June 2026 .13 minute read
DLA Piper advises Einride on business combination and U.S. listing
16 June 2026 .2 minute read
